Biochemical rationales for the selection of combinations of chemotherapeutic agents.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003513:Cycloheximide / Q000494:pharmacology / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000096:biosynthesis / Q000378:metabolism; D004359:Drug Therapy, Combination; D006918:Hydroxyurea / Q000494:pharmacology / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy; D008870:Microtubules / Q000378:metabolism; D008938:Mitosis / Q000187:drug effects; D009374:Neoplasms, Experimental / Q000188:drug therapy; D014176:Protein Biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis / Q000378:metabolism; D013995:Time
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D003513:Cycloheximide; D006918:Hydroxyurea